NALLELI MALDONADO: Open Payments
NPI 1588405948 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 22 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $151 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Radius Health, Inc. | 3 | $69 |
| Lilly USA, LLC | 3 | $65 |
| Dexcom, Inc. | 2 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Almatica Pharma LLC | 2 | $33 |
| Astellas Pharma US Inc | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Ascensia Diabetes Care Us Inc. | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
Products named: Tymlos, MOUNJARO, Dexcom G6 Transmitter, AIRSUPRA, JARDIANCE, Veozah, Kerendia, FARXIGA.
Industry payments across CA — which companies pay providers there.
